Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7934
Title: Novel Ret Mutations in Macedonian Patients with Medullary Thyroid Carcinoma: Genotype-Phenotype Correlations/ Нови Ret-Мутации Кај Македонски Пациенти Со Медуларен Карцином На Тироидната Жлезда: Генотипско-Фенотипски Корелации
Authors: Jovanovic, Rubens 
Kostadinova-Kunovska, Slavica 
Janevska, Vesna 
Bogoeva, Biljana
Spasevska, Liljana 
Miladinova, Daniela 
Ugrinska, Ana 
Zdraveska-Kochovska, Marina
Trajkov, Dejan 
Petrusevska, Gordana
Keywords: RET mutations, Medullary thyroid carcinoma, Ki-67, Bcl-2
Issue Date: 1-May-2015
Publisher: Walter de Gruyter GmbH / MANU
Journal: PRILOZI
Abstract: Medullary thyroid carcinomas (MTCs) are rare neoplasms comprising 2-10% of all thyroid malignnancies. More than 75% are sporadic tumors and the remainder is familial and MEN2 related. Both sporadic and syndromic MTCs frequently show mutations in the RET proto-oncogene. It has been noted that some MTC cases present an indolent, and some an aggressive clinical course. Ki-67 expression is generally low, with documented exceptions, whereas high expression of Bcl-2 has been reported in majority of the cases. Some studies have shown that Ki-67 and Bcl-2 expressions have prognostic value, as well as RET mutational status. We analyzed 20 unrelated MTC cases for Ki-67, Bcl-2 expression and RET mutations and tested their intercorrelations, correlations to the morphologic features and stage of the tumors, as well as their influence on survival. In 13 of the 20 analyzed cases we found 23 sequence changes distributed in exons 8, 10-13 and 16. There were 11 different missense mutations, single nucleotide deletion with frameshift, and 8 different synonymous mutations. Only 4 of the sequence changes have been previously published. Twelve patients (60%) had tumors expressing one or more missense mutations or single nucleotide deletion and 7 of them (35%) had at least one damaging or possibly damaging RET mutation. Most of the tumors had low Ki-67 expression (mean 6.48% of cells) and high Bcl-2 expression (mean 68.3%). Significantly better survival was observed in cases with low Ki-67 (< 6.5%; p < 0.05), high Bcl-2 expression (> 68.3%; p < 0.01) and younger age at diagnosis (< 51 years; p < 0.05).
URI: http://hdl.handle.net/20.500.12188/7934
DOI: 10.1515/prilozi-2015-0034
Appears in Collections:Faculty of Medicine: Journal Articles

Show full item record

Page view(s)

10
checked on Dec 3, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.